The Australian Government Simplifies the Clinical Eligibility Criteria for the Continuous Glucose Monitoring (CGM) Initiative
The Australian Government Simplifies the Clinical Eligibility Criteria for the Continuous Glucose Monitoring (CGM) Initiative
Sydney, Australia, March 2020
The Australian Government is simplifying the clinical eligibility criteria for the Continuous Glucose Monitoring (CGM) Initiative from the 1st of March, 2020. This will allow people with type 1 diabetes under the age of 21, and those over the age of 21 who have valid concessional status to access fully subsidised CGM devices through the National Diabetes Services Scheme (NDSS).
Both Dexcom G5 Mobile and Dexcom G4 PLATINUM Systems are available to eligible patients who meet the new eligibility criteria for one of the following groups:
- Children and young people under 21 years with type 1 diabetes
- People with type 1 diabetes aged 21 years or older who have valid concessional status
- Children and young people under 21 years with conditions very similar to type 1 diabetes who require insulin, such as cystic fibrosis-related diabetes and neonatal diabetes.
Patients or healthcare professionals can visit our website for more information, or visit NDSS at www.ndss.com.au/CGM.
The Australian Government Simplifies the Clinical Eligibility Criteria for the Continuous Glucose Monitoring (CGM) Initiative
Other News
Introducing the Basal-IQ Technology Update for the t:slim X2 Insulin Pump
Important Dexcom Update
Important Update:
